<?xml version="1.0" encoding="UTF-8"?>
<ref id="B63-molecules-26-00431">
 <label>63.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Gomes</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Raimundo</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Soares</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Loureiro</surname>
    <given-names>J.B.</given-names>
   </name>
   <name>
    <surname>Le√£o</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Ramos</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Monteiro</surname>
    <given-names>M.N.</given-names>
   </name>
   <name>
    <surname>Lemos</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Moreira</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Pinto</surname>
    <given-names>M.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>New inhibitor of the TAp73 interaction with MDM2 and mutant p53 with promising antitumor activity against neuroblastoma</article-title>
  <source>Cancer Lett.</source>
  <year>2019</year>
  <volume>446</volume>
  <fpage>90</fpage>
  <lpage>102</lpage>
  <pub-id pub-id-type="doi">10.1016/j.canlet.2019.01.014</pub-id>
  <?supplied-pmid 30664963?>
  <pub-id pub-id-type="pmid">30664963</pub-id>
 </element-citation>
</ref>
